|
|||||
|
|
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinoma |
|
| Authors: | Bhishamjit S. Chera MD Siddharth H. Sheth DO Shetal A. Patel MD PhD Dan Goldin MSW Kathe E. Douglas BA Rebecca L. Green MSW Colette J. Shen MD PhD Gaorav P. Gupta MD PhD Dominic T. Moore MPH Juneko E. Grilley Olson MD Jared M. Weiss MD |
| Affiliation: | 1. Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;2. Lineberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill, North Carolina;3. Lineberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill, North Carolina Department of Medicine, Division of Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina;4. Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina Hospitals, Chapel Hill, North Carolina |
| Abstract: | |
| Keywords: | adavosertib chemotherapy head and neck cancer phase 1 radiation WEE1 |